120 likes | 135 Views
The PORT Study aims to develop a model for identifying low-risk patients with community-acquired pneumonia (CAP) to guide hospitalization decisions based on readily available ED information. The prediction rule helps classify patients into risk classes and determine appropriate management strategies. Study phases included retrospective and prospective data analysis, with outcomes focusing on 30-day hospital mortality and related events. The evidence supports using the prediction rule to differentiate low-risk patients who may not require conventional hospitalization.
E N D
Evidence in the EDThe Port Study Identifying Low Risk Patients with Community Acquired Pneumonia Zachary Meisel, MD, MPH
The PORT Study • Goals of Study: • Develop and validate a model for predicting prognosis for patients with community acquired pneumonia (CAP). • Improve decisions about hospitalizing patients with CAP with information readily available in ED or office. Fine MJ, Auble TE, Yealy DM. A prediction rule to identify low risk patients with community acquired pneumonia. N Engl J Med 1997; 336: 243-250
Patients with CAP The Rule (step 1) Age over 50? Yes No • Co-existing conditions: • Neoplastic disease • CHF • Cerebrovascular Disease • Renal Disease • Liver Disease Risk Class II-V Yes Yes Yes No Altered Mental Status Pulse >125 Resp Rate > 30/min SBP <90 mm Hg Temp less than 35 C or greater than 40 C Yes Risk Class I No
PORT prediction rule Step 2 • Identifies patients in risk classes II, III, IV, V. • Includes lab and xray findings • Total points by summing pt’s age and points for each characteristic. • Class II: <70 • Class III: 71-90 • Class IV: 91-130 • Class V: >130
Nursing home residence: 10 pts Neoplastic disease: 30 pts Liver disease: 20 pts CHF: 10 pts Cerebrovascular disease: 10 pts Renal disease: 10 pts Altered mental status: 20 pts Respiratory rate >30/min: 20 pts SBP <90: 20 pts Temp <35 or >40: 15 pts Pulse >125: 10 pts Arterial pH <7.35: 30 pts BUN >30 mg/dL: 20 pts Serum sodium <130 mmol/liter: 20 pts Glucose >250 mg/dL: 10 pts Hct <30%: 10 pts Pa02 <60 mm Hgb: 10 pts Pleural Effusion: 10 pts Prediction Rule Step 2
The Evidence • 3 phase study design • 54,000 patients used to derive, retrospectively validate, and then prospectively validate the rules. • Retrospective and prospective data used. • Outcomes evaluated: • Primary: 30 day hospital mortality • Secondary: repeat hospitalizations, intensive care unit admission, length of hospital stay.
Derivation of rules • Retrospective data • 14,000 inpatients from 1989 database • Included: patients >18 with primary diagnosis of CAP • Excluded: HIV or recent hospitalization • Outcome: 30 day hospital mortality
Validation of Rules • 39,000 patients evaluated from multihospital database • Retrospective • Inpatients • 2287 patients evaluated in “PORT cohort” • Prospective • Outpatients and Inpatients
Results/Summary • Patients in risk class I, II and III have low risk from dying and other adverse events from CAP. • Outpatient or abbreviated inpatient therapy may be appropriate. • The prediction rule was consistent across the 2 retrospective cohorts as well as the prospective group.
HUPisms • Patients younger than 50 with CAP who have none of the coexisting illnesses or vital sign abnormalities listed in step one: • Can be classified into risk group I • Can most likely be safely discharged from the ED.
EM take home points • Patients who fail step 1, may need ancillary testing but still may be low enough risk to be discharged safely. • Patients who are hypoxic or unable to obtain follow up and/or antibiotics may require admission despite being classified as low risk under the PORT prediction rules